nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyl aminolevulinate—Squamous cell carcinoma—Medroxyprogesterone Acetate—uterine cancer	0.0944	0.0944	CcSEcCtD
Methyl aminolevulinate—Macular oedema—Medroxyprogesterone Acetate—uterine cancer	0.0878	0.0878	CcSEcCtD
Methyl aminolevulinate—Ulcer—Medroxyprogesterone Acetate—uterine cancer	0.0227	0.0227	CcSEcCtD
Methyl aminolevulinate—Swelling—Progesterone—uterine cancer	0.0195	0.0195	CcSEcCtD
Methyl aminolevulinate—Sensitisation—Epirubicin—uterine cancer	0.019	0.019	CcSEcCtD
Methyl aminolevulinate—Ulcer—Dactinomycin—uterine cancer	0.0177	0.0177	CcSEcCtD
Methyl aminolevulinate—Swelling—Medroxyprogesterone Acetate—uterine cancer	0.0176	0.0176	CcSEcCtD
Methyl aminolevulinate—Sensitisation—Doxorubicin—uterine cancer	0.0176	0.0176	CcSEcCtD
Methyl aminolevulinate—Face oedema—Progesterone—uterine cancer	0.0166	0.0166	CcSEcCtD
Methyl aminolevulinate—Infection—Carboplatin—uterine cancer	0.016	0.016	CcSEcCtD
Methyl aminolevulinate—Face oedema—Medroxyprogesterone Acetate—uterine cancer	0.015	0.015	CcSEcCtD
Methyl aminolevulinate—Pain—Carboplatin—uterine cancer	0.0137	0.0137	CcSEcCtD
Methyl aminolevulinate—Ulcer—Etoposide—uterine cancer	0.0128	0.0128	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Etoposide—uterine cancer	0.0116	0.0116	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Epirubicin—uterine cancer	0.0114	0.0114	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Progesterone—uterine cancer	0.0111	0.0111	CcSEcCtD
Methyl aminolevulinate—Skin hyperpigmentation—Doxorubicin—uterine cancer	0.0105	0.0105	CcSEcCtD
Methyl aminolevulinate—Keratitis—Epirubicin—uterine cancer	0.0105	0.0105	CcSEcCtD
Methyl aminolevulinate—Erythema—Progesterone—uterine cancer	0.0103	0.0103	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.0101	0.0101	CcSEcCtD
Methyl aminolevulinate—Swelling—Etoposide—uterine cancer	0.00995	0.00995	CcSEcCtD
Methyl aminolevulinate—Burning sensation—Epirubicin—uterine cancer	0.00976	0.00976	CcSEcCtD
Methyl aminolevulinate—Keratitis—Doxorubicin—uterine cancer	0.00967	0.00967	CcSEcCtD
Methyl aminolevulinate—Blister—Epirubicin—uterine cancer	0.00941	0.00941	CcSEcCtD
Methyl aminolevulinate—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.00937	0.00937	CcSEcCtD
Methyl aminolevulinate—Burning sensation—Doxorubicin—uterine cancer	0.00903	0.00903	CcSEcCtD
Methyl aminolevulinate—Skin ulcer—Epirubicin—uterine cancer	0.00871	0.00871	CcSEcCtD
Methyl aminolevulinate—Blister—Doxorubicin—uterine cancer	0.00871	0.00871	CcSEcCtD
Methyl aminolevulinate—Discomfort—Progesterone—uterine cancer	0.0087	0.0087	CcSEcCtD
Methyl aminolevulinate—Rash pustular—Epirubicin—uterine cancer	0.0085	0.0085	CcSEcCtD
Methyl aminolevulinate—Oedema—Progesterone—uterine cancer	0.00844	0.00844	CcSEcCtD
Methyl aminolevulinate—Infection—Progesterone—uterine cancer	0.00838	0.00838	CcSEcCtD
Methyl aminolevulinate—Stinging—Epirubicin—uterine cancer	0.00837	0.00837	CcSEcCtD
Methyl aminolevulinate—Skin ulcer—Doxorubicin—uterine cancer	0.00806	0.00806	CcSEcCtD
Methyl aminolevulinate—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00788	0.00788	CcSEcCtD
Methyl aminolevulinate—Rash pustular—Doxorubicin—uterine cancer	0.00787	0.00787	CcSEcCtD
Methyl aminolevulinate—Stinging—Doxorubicin—uterine cancer	0.00775	0.00775	CcSEcCtD
Methyl aminolevulinate—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00765	0.00765	CcSEcCtD
Methyl aminolevulinate—Infection—Medroxyprogesterone Acetate—uterine cancer	0.0076	0.0076	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Progesterone—uterine cancer	0.00758	0.00758	CcSEcCtD
Methyl aminolevulinate—Erythema—Dactinomycin—uterine cancer	0.00731	0.00731	CcSEcCtD
Methyl aminolevulinate—Fatigue—Progesterone—uterine cancer	0.00727	0.00727	CcSEcCtD
Methyl aminolevulinate—Pain—Progesterone—uterine cancer	0.00722	0.00722	CcSEcCtD
Methyl aminolevulinate—Ulcer—Epirubicin—uterine cancer	0.00717	0.00717	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00687	0.00687	CcSEcCtD
Methyl aminolevulinate—Urticaria—Progesterone—uterine cancer	0.0067	0.0067	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Epirubicin—uterine cancer	0.0067	0.0067	CcSEcCtD
Methyl aminolevulinate—Ulcer—Doxorubicin—uterine cancer	0.00663	0.00663	CcSEcCtD
Methyl aminolevulinate—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00659	0.00659	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Epirubicin—uterine cancer	0.00647	0.00647	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Progesterone—uterine cancer	0.00622	0.00622	CcSEcCtD
Methyl aminolevulinate—Dermatitis contact—Doxorubicin—uterine cancer	0.0062	0.0062	CcSEcCtD
Methyl aminolevulinate—Discomfort—Dactinomycin—uterine cancer	0.00615	0.00615	CcSEcCtD
Methyl aminolevulinate—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00607	0.00607	CcSEcCtD
Methyl aminolevulinate—Asthenia—Progesterone—uterine cancer	0.00605	0.00605	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Doxorubicin—uterine cancer	0.00599	0.00599	CcSEcCtD
Methyl aminolevulinate—Pruritus—Progesterone—uterine cancer	0.00597	0.00597	CcSEcCtD
Methyl aminolevulinate—Oedema—Dactinomycin—uterine cancer	0.00596	0.00596	CcSEcCtD
Methyl aminolevulinate—Infection—Dactinomycin—uterine cancer	0.00592	0.00592	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Etoposide—uterine cancer	0.00568	0.00568	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00563	0.00563	CcSEcCtD
Methyl aminolevulinate—Dizziness—Progesterone—uterine cancer	0.00558	0.00558	CcSEcCtD
Methyl aminolevulinate—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00549	0.00549	CcSEcCtD
Methyl aminolevulinate—Eczema—Epirubicin—uterine cancer	0.00548	0.00548	CcSEcCtD
Methyl aminolevulinate—Eye pain—Epirubicin—uterine cancer	0.00545	0.00545	CcSEcCtD
Methyl aminolevulinate—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00541	0.00541	CcSEcCtD
Methyl aminolevulinate—Rash—Progesterone—uterine cancer	0.00532	0.00532	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Progesterone—uterine cancer	0.00532	0.00532	CcSEcCtD
Methyl aminolevulinate—Headache—Progesterone—uterine cancer	0.00529	0.00529	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Epirubicin—uterine cancer	0.00515	0.00515	CcSEcCtD
Methyl aminolevulinate—Fatigue—Dactinomycin—uterine cancer	0.00514	0.00514	CcSEcCtD
Methyl aminolevulinate—Pain—Dactinomycin—uterine cancer	0.0051	0.0051	CcSEcCtD
Methyl aminolevulinate—Eczema—Doxorubicin—uterine cancer	0.00507	0.00507	CcSEcCtD
Methyl aminolevulinate—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00506	0.00506	CcSEcCtD
Methyl aminolevulinate—Eye pain—Doxorubicin—uterine cancer	0.00505	0.00505	CcSEcCtD
Methyl aminolevulinate—Nausea—Progesterone—uterine cancer	0.00501	0.00501	CcSEcCtD
Methyl aminolevulinate—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00482	0.00482	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00482	0.00482	CcSEcCtD
Methyl aminolevulinate—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00479	0.00479	CcSEcCtD
Methyl aminolevulinate—Dermatitis bullous—Doxorubicin—uterine cancer	0.00477	0.00477	CcSEcCtD
Methyl aminolevulinate—Face oedema—Epirubicin—uterine cancer	0.00475	0.00475	CcSEcCtD
Methyl aminolevulinate—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00454	0.00454	CcSEcCtD
Methyl aminolevulinate—Discomfort—Etoposide—uterine cancer	0.00445	0.00445	CcSEcCtD
Methyl aminolevulinate—Face oedema—Doxorubicin—uterine cancer	0.0044	0.0044	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Dactinomycin—uterine cancer	0.00439	0.00439	CcSEcCtD
Methyl aminolevulinate—Infection—Etoposide—uterine cancer	0.00429	0.00429	CcSEcCtD
Methyl aminolevulinate—Asthenia—Dactinomycin—uterine cancer	0.00428	0.00428	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Epirubicin—uterine cancer	0.00388	0.00388	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Etoposide—uterine cancer	0.00388	0.00388	CcSEcCtD
Methyl aminolevulinate—Rash—Dactinomycin—uterine cancer	0.00376	0.00376	CcSEcCtD
Methyl aminolevulinate—Fatigue—Etoposide—uterine cancer	0.00372	0.00372	CcSEcCtD
Methyl aminolevulinate—Pain—Etoposide—uterine cancer	0.00369	0.00369	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00359	0.00359	CcSEcCtD
Methyl aminolevulinate—Nausea—Dactinomycin—uterine cancer	0.00354	0.00354	CcSEcCtD
Methyl aminolevulinate—Urticaria—Etoposide—uterine cancer	0.00343	0.00343	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Epirubicin—uterine cancer	0.00318	0.00318	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Etoposide—uterine cancer	0.00318	0.00318	CcSEcCtD
Methyl aminolevulinate—Asthenia—Etoposide—uterine cancer	0.0031	0.0031	CcSEcCtD
Methyl aminolevulinate—Pruritus—Etoposide—uterine cancer	0.00305	0.00305	CcSEcCtD
Methyl aminolevulinate—Erythema—Epirubicin—uterine cancer	0.00296	0.00296	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Doxorubicin—uterine cancer	0.00294	0.00294	CcSEcCtD
Methyl aminolevulinate—Dizziness—Etoposide—uterine cancer	0.00285	0.00285	CcSEcCtD
Methyl aminolevulinate—Erythema—Doxorubicin—uterine cancer	0.00274	0.00274	CcSEcCtD
Methyl aminolevulinate—Rash—Etoposide—uterine cancer	0.00272	0.00272	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Etoposide—uterine cancer	0.00272	0.00272	CcSEcCtD
Methyl aminolevulinate—Headache—Etoposide—uterine cancer	0.0027	0.0027	CcSEcCtD
Methyl aminolevulinate—Nausea—Etoposide—uterine cancer	0.00256	0.00256	CcSEcCtD
Methyl aminolevulinate—Discomfort—Epirubicin—uterine cancer	0.00249	0.00249	CcSEcCtD
Methyl aminolevulinate—Oedema—Epirubicin—uterine cancer	0.00242	0.00242	CcSEcCtD
Methyl aminolevulinate—Infection—Epirubicin—uterine cancer	0.0024	0.0024	CcSEcCtD
Methyl aminolevulinate—Discomfort—Doxorubicin—uterine cancer	0.00231	0.00231	CcSEcCtD
Methyl aminolevulinate—Oedema—Doxorubicin—uterine cancer	0.00224	0.00224	CcSEcCtD
Methyl aminolevulinate—Infection—Doxorubicin—uterine cancer	0.00222	0.00222	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Epirubicin—uterine cancer	0.00217	0.00217	CcSEcCtD
Methyl aminolevulinate—Fatigue—Epirubicin—uterine cancer	0.00209	0.00209	CcSEcCtD
Methyl aminolevulinate—Pain—Epirubicin—uterine cancer	0.00207	0.00207	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Doxorubicin—uterine cancer	0.00201	0.00201	CcSEcCtD
Methyl aminolevulinate—Fatigue—Doxorubicin—uterine cancer	0.00193	0.00193	CcSEcCtD
Methyl aminolevulinate—Urticaria—Epirubicin—uterine cancer	0.00192	0.00192	CcSEcCtD
Methyl aminolevulinate—Pain—Doxorubicin—uterine cancer	0.00191	0.00191	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Epirubicin—uterine cancer	0.00178	0.00178	CcSEcCtD
Methyl aminolevulinate—Urticaria—Doxorubicin—uterine cancer	0.00178	0.00178	CcSEcCtD
Methyl aminolevulinate—Asthenia—Epirubicin—uterine cancer	0.00174	0.00174	CcSEcCtD
Methyl aminolevulinate—Pruritus—Epirubicin—uterine cancer	0.00171	0.00171	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Doxorubicin—uterine cancer	0.00165	0.00165	CcSEcCtD
Methyl aminolevulinate—Asthenia—Doxorubicin—uterine cancer	0.00161	0.00161	CcSEcCtD
Methyl aminolevulinate—Dizziness—Epirubicin—uterine cancer	0.0016	0.0016	CcSEcCtD
Methyl aminolevulinate—Pruritus—Doxorubicin—uterine cancer	0.00158	0.00158	CcSEcCtD
Methyl aminolevulinate—Rash—Epirubicin—uterine cancer	0.00153	0.00153	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Epirubicin—uterine cancer	0.00152	0.00152	CcSEcCtD
Methyl aminolevulinate—Headache—Epirubicin—uterine cancer	0.00152	0.00152	CcSEcCtD
Methyl aminolevulinate—Dizziness—Doxorubicin—uterine cancer	0.00148	0.00148	CcSEcCtD
Methyl aminolevulinate—Nausea—Epirubicin—uterine cancer	0.00144	0.00144	CcSEcCtD
Methyl aminolevulinate—Rash—Doxorubicin—uterine cancer	0.00141	0.00141	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Doxorubicin—uterine cancer	0.00141	0.00141	CcSEcCtD
Methyl aminolevulinate—Headache—Doxorubicin—uterine cancer	0.0014	0.0014	CcSEcCtD
Methyl aminolevulinate—Nausea—Doxorubicin—uterine cancer	0.00133	0.00133	CcSEcCtD
